Status:
COMPLETED
Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
Lead Sponsor:
University of South Alabama
Collaborating Sponsors:
Takeda
Sucampo Pharmaceuticals, Inc.
Conditions:
Inflammatory Bowel Disease
Eligibility:
All Genders
19-90 years
Phase:
PHASE4
Brief Summary
This investigation is designed to compare lubiprostone and placebo for cleansing and propulsion in preparation for capsule endoscopy.
Detailed Description
Introduction of small bowel capsule endoscopy made available an unique technique for diagnostic evaluation of the gastrointestinal tract. After esophagogastroduodenoscopy and colonoscopy about 5% of b...
Eligibility Criteria
Inclusion
- Healthy volunteers
Exclusion
- Gi disorders, gi surgery, cardiac, renal, or hepatic insufficiency, severe diarrhea
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00746395
Start Date
April 1 2008
End Date
September 1 2008
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USA Pavilion at Infirmary West
Mobile, Alabama, United States, 36693